Minerva Neurosciences Stock Annual Yield
NERV Stock | USD 2.26 0.04 1.80% |
Minerva Neurosciences fundamentals help investors to digest information that contributes to Minerva Neurosciences' financial success or failures. It also enables traders to predict the movement of Minerva Stock. The fundamental analysis module provides a way to measure Minerva Neurosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Minerva Neurosciences stock.
Minerva |
Minerva Neurosciences Company Annual Yield Analysis
Minerva Neurosciences' Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Minerva Neurosciences has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
Minerva Fundamentals
Return On Equity | -6.75 | ||||
Return On Asset | -0.29 | ||||
Current Valuation | (10.76 M) | ||||
Shares Outstanding | 6.99 M | ||||
Shares Owned By Insiders | 22.26 % | ||||
Shares Owned By Institutions | 30.47 % | ||||
Number Of Shares Shorted | 23.38 K | ||||
Price To Earning | 69.58 X | ||||
Price To Book | 2.68 X | ||||
Price To Sales | 1.87 X | ||||
Gross Profit | (16.84 M) | ||||
EBITDA | (21.69 M) | ||||
Net Income | (30.01 M) | ||||
Cash And Equivalents | 40.22 M | ||||
Cash Per Share | 7.53 X | ||||
Total Debt | 82.02 M | ||||
Debt To Equity | 0 % | ||||
Current Ratio | 20.41 X | ||||
Book Value Per Share | (3.10) X | ||||
Cash Flow From Operations | (14.78 M) | ||||
Short Ratio | 0.96 X | ||||
Earnings Per Share | (0.45) X | ||||
Target Price | 5.0 | ||||
Beta | 0.17 | ||||
Market Capitalization | 15.77 M | ||||
Total Asset | 56.9 M | ||||
Retained Earnings | (396.82 M) | ||||
Working Capital | 38.66 M | ||||
Current Asset | 33.48 M | ||||
Current Liabilities | 5.32 M | ||||
Net Asset | 56.9 M |
About Minerva Neurosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Minerva Neurosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Minerva Neurosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Minerva Neurosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.